SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 5th, 2019 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 15, 2019, by and between CEREBAIN BIOTECH CORP., a Nevada corporation, with headquarters located at 600 Anton Blvd., Suite 1100, Costa Mesa, CA 92626 (the “Company”), and AUCTUS FUND, LLC, a Delaware limited liability company, with its address at 545 Boylston Street, 2nd Floor, Boston, MA 02116 (the “Buyer”).
COMMON STOCK PURCHASE WARRANT CEREBAIN BIOTECH CORP.Security Agreement • April 5th, 2019 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies • Nevada
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the funding of the purchase price of $55,000.00 for the first tranche of $55,000.00 under the $110,000.00 convertible promissory note to the Holder (as defined below) of even date) (the “Note”), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the ”Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Cerebain Biotech Corp., a Nevada corporation (the ”Company”), up to 1,100,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain secur
AMENDMENT #1 TO THE CONVERTIBLE PROMISSORY NOTE ISSUED ON FEBRUARY 14, 2018Convertible Promissory Note Amendment • April 5th, 2019 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies
THIS AMENDMENT #1 TO THE CONVERTIBLE PROMISSORY NOTE ISSUED ON February 14, 2018 (the “Amendment”) is entered into by and between Cerebain Biotech Corp., a Nevada corporation (the “Company”), and Crown Bridge Partners, LLC, a New York limited liability company (the “Holder”) (collectively the “Parties”).
FIRST AMENDMENT TO PROMISSORY NOTEPromissory Note • April 5th, 2019 • Cerebain Biotech Corp. • Wholesale-medical, dental & hospital equipment & supplies
THIS FIRST AMENDMENT TO PROMISSORY NOTE (the “Amendment”), dated as of March 26, 2019 (the “Effective Date”), is entered into by Cerebain Biotech Corp. (the “Company”) and Auctus Fund, LLC (“Holder”).
